The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Tuesday, April 29, 2014
Stem Cell Study in ALS Patients Gets FDA Green Light
The FDA has OK'd the start of a phase II clinical trial of NurOwn in patients with amyotrophic lateral sclerosis , commonly known as Lou Gehrig's disease.
No comments:
Post a Comment